Fortress Biotech, Inc. — Form 4
Filed November 19, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 58/100
What the filing says
PRESIDENT, CEO & CHAIRMAN ROSENWALD LINDSAY A MD (FBIO) bought 137K shares (~$253K) on the open market (2.8% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.